The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Synaptic plasticity and mood disorders
Abstract
Recent studies demonstrate that the molecular elements known to regulate neuronal plasticity in models of learning and memory are also involved in the actions of drugs used for the treatment of depression and bipolar disorder. This includes up-regulation of transcription factors, such as the cAMP response element binding protein and neurotrophic factors, such as brain derived neurotrophic factor. These findings raise the possibility that regulation of neural plasticity in specific neuronal circuits is integrally involved in the therapeutic intervention of mood disorders. Atypical antipsychotic drugs, including clozapine and olanzapine, are also effective for the treatment of bipolar disorder, and are used as add-on medication for unipolar depression. The possibility that these atypical antipsychotic drugs also influence the molecular determinants of synaptic plasticity that are involved in the response to drugs used for the treatment of mood disorders, is discussed.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The relationship of LTP during waking to increased production of slow waves in sleep is likely relevant for depression, in that most effective antidepressants increase expression of plasticity-related genes (reviewed in Duman, 2002; Payne et al., 2002) much like sleep deprivation (Cirelli et al., 2004), although on a longer time course.”
From Biological rhythms, higher brain function, and behavior: Gaps, opportunities, and challenges (2009) · cites this paper as Duman, 2002
Citations
Cites
Gage, F. H. (2000) · Science · doi:10.1126/science.287.5457.1433 · Cited by 4,786
Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus
Malberg, J. E., Eisch, A. J., Nestler, E. J., & Duman, R. S. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-24-09104.2000 · Cited by 3,111
Subgenual prefrontal cortex abnormalities in mood disorders
Drevets, W. C., Price, J. L., Simpson, J. R., Todd, R. D., Reich, T., Vannier, M., & Raichle, M. E. (1997) · Nature · doi:10.1038/386824a0 · Cited by 2,693
A molecular and cellular theory of depression
Duman, R. S. (1997) · Archives of General Psychiatry · doi:10.1001/archpsyc.1997.01830190015002 · Cited by 2,129
Nibuya, M., Morinobu, S., & Duman, R. (1995) · The Journal of Neuroscience · doi:10.1523/jneurosci.15-11-07539.1995 · Cited by 2,109
STRESS AND HIPPOCAMPAL PLASTICITY
McEwen, B. S. (1999) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.22.1.105 · Cited by 2,087
Hippocampal atrophy in recurrent major depression
Sheline, Y. I., Wang, P. W., Gado, M. H., Csernansky, J. G., & Vannier, M. W. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.9.3908 · Cited by 1,932
Bonni, A., Brunet, A., West, A. E., Datta, S. R., Takasu, M. A., & Greenberg, M. E. (1999) · Science · doi:10.1126/science.286.5443.1358 · Cited by 1,908
McEwen, B. S., & Sapolsky, R. M. (1995) · Current Opinion in Neurobiology · doi:10.1016/0959-4388(95)80028-x · Cited by 1,889
Hippocampal Volume Reduction in Major Depression
Bremner, J. D., Narayan, M., Anderson, E. R., Staib, L. H., Miller, H. L., & Charney, D. S. (2000) · American Journal of Psychiatry · doi:10.1176/ajp.157.1.115 · Cited by 1,670
Research works printed but not linked: 4
- Thome J, Sakai N, Shin KH, Steffen C, Impey S, Storm DR et al. Regulation of cAMP-response-element promoter activity by antidepressant treatment in CRE-lacZ transgenic mice Soc Neurosci 1998 24: 1844
- Shirayama Y, Chen ACH, Duman RS . Antidepressant-like effects of BDNF and NT-3 in behavioral models of depression Soc Neurosci 2000 26: 1042
- Jacobs B, Fornal CA . Chronic fluoxetine treatment increases hippocampal neurogenesis in rats: a novel theory of depression Soc Neurosci Abstracts, Miami, FL 1999
- Kim J-E, Nakagawa S, Duman RS . Chronic administration of rolipram, a cAMP phosphodiesterase-4 inhibitor, upregulates neurogenesis in the adult mouse hippocampus Soc Neurosci Abs 2000 26: 2316
Cited by
Sorted by citations
Items 201–300 of 363
Convergences in Course of Illness and Treatments of the Epilepsies and Recurrent Affective Disorders
Post, R. M., & Weiss, S. R. B. (2004) · Clinical EEG and Neuroscience · doi:10.1177/155005940403500108 · Cited by 25
The interaction between BDNF and DRD2 in Bipolar II disorder but not in bipolar i disorder
Huang, C., Chang, Y., Lee, S.-Y., Chen, S., Chen, S., Chu, C., Huang, S., Tzeng, N., Lee, I. H., Yeh, T. L., et al. (2012) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.32055 · Cited by 25
DHEA provides a microenvironment for endometrial stem cells neurogenesis
Shoae‐Hassani, A., Mortazavi‐Tabatabaei, S. A., Sharif, S., Rezaei-Khaligh, H., & Verdi, J. (2011) · Medical Hypotheses · doi:10.1016/j.mehy.2011.02.033 · Cited by 25
Park, M.-H., Chang, K., Hallmayer, J. F., Howe, M. E., Kim, E. J., Hong, S., & Singh, M. K. (2014) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2014.11.013 · Cited by 23
Inkster, B., Zai, G. C., Lewis, G., & Miskowiak, K. W. (2018) · Translational Psychiatry · doi:10.1038/s41398-018-0270-z · Cited by 23
Controversies about a common etiology for eating and mood disorders
Rossetti, C., Halfon, O., & Boutrel, B. (2014) · Frontiers in Psychology · doi:10.3389/fpsyg.2014.01205 · Cited by 25
Brain‐derived neurotrophic factor (BDNF) gene not associated with antidepressant‐induced mania
Zai, G. C., Mundo, E., Strauss, J., Wong, G. W. H., & Kennedy, J. L. (2007) · Bipolar Disorders · doi:10.1111/j.1399-5618.2007.00416.x · Cited by 22
Birmann, P. T., Casaril, A. M., Hartwig, D., Jacob, R. G., Seixas, F. K., Collares, T. V., & Savegnago, L. (2020) · Brain Research · doi:10.1016/j.brainres.2020.146880 · Cited by 21
Association study of BDNF with completed suicide in the Japanese population
Ratta‐apha, W., Hishimoto, A., Yoshida, M., Ueno, Y., Asano, M., Shirakawa, O., & Sora, I. (2013) · Psychiatry Research · doi:10.1016/j.psychres.2013.05.030 · Cited by 21
Interaction of the DRD3 and BDNF gene variants in subtyped bipolar disorder
Lee, S.-Y., Chen, S., Chen, S., Chu, C., Chang, Y., Lin, S., Huang, S., Tzeng, N., Kuo, P., Lee, I. H., et al. (2012) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2012.07.015 · Cited by 20
Genetic Alterations of the Murine Serotonergic Gene Pathway: The Neurodevelopmental Basis of Anxiety
Lesch, K. (2005) · Handbook of experimental pharmacology · doi:10.1007/3-540-28082-0_3 · Cited by 22
Satvat, E., Gheidi, A., Voll, S., Odintsova, I. V., & Marrone, D. F. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.11.025 · Cited by 18
Liu, D., Shi, Q., Zhang, J., Li, T., Xiong, L., Dai, S., & Huang, J. D. (2022) · Advanced Intelligent Systems · doi:10.1002/aisy.202200164 · Cited by 20
The hippocampus and executive functions in depression
Khan, S., Ryali, V., Bhat, P., Prakash, J., Srivastava, K., & Khanam, S. (2015) · Industrial Psychiatry Journal · doi:10.4103/0972-6748.160920 · Cited by 19
Evidence for Global Reduction in Brain Cyclic Adenosine Monophosphate Signaling in Depression
O’Donnell, J. M., & Xu, Y. (2012) · Biological Psychiatry · doi:10.1016/j.biopsych.2012.07.017 · Cited by 20
COMT and BDNF interacted in bipolar II disorder not comorbid with anxiety disorder
Lee, S.-Y., Chen, S., Wang, Y., Chang, Y., Huang, S., Tzeng, N., Lee, I. H., Yeh, T. L., Yang, Y. K., & Lu, R. (2012) · Behavioural Brain Research · doi:10.1016/j.bbr.2012.09.039 · Cited by 21
TrkB partial agonists: Potential treatment strategy for major depression
Tsai, S. (2006) · Medical Hypotheses · doi:10.1016/j.mehy.2006.06.019 · Cited by 20
Hou, S.-J., Yen, F.-C., & Tsai, S. (2008) · Medical Hypotheses · doi:10.1016/j.mehy.2008.09.009 · Cited by 20
Effects of the Synthetic Neurosteroid
Parésys, L., Hoffmann, K., Froger, N., Bianchi, M., Villey, I., Baulieu, É.-É., & Fuchs, E. (2015) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyv119 · Cited by 20
Soler, C. T., Kanders, S. H., Olofsdotter, S., Vadlin, S., Åslund, C., & Nilsson, K. W. (2022) · Genes · doi:10.3390/genes13071236 · Cited by 19
Lee, S.-Y., Wang, T., Chen, S., Chang, Y., Chen, P. S., Huang, S., Tzeng, N., Wang, L., Lee, I., Chen, K.-C., et al. (2020) · International Journal of Bipolar Disorders · doi:10.1186/s40345-019-0174-8 · Cited by 19
Peng, S.-X., Wang, Y., Zhang, M., Zang, Y., Wu, D., Pei, J., Li, Y., Dai, J., Guo, X., Luο, X., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-91415-9 · Cited by 18
Dazzi, L., Seu, E., Cherchi, G., & Biggio, G. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2003.11.020 · Cited by 18
Does Dual Antidepressant Therapy as Initial Treatment Hasten and Increase Remission from Depression?
Stewart, J. W., McGrath, P. J., Deliyannides, R. A., & Quitkin, F. M. (2009) · Journal of Psychiatric Practice · doi:10.1097/01.pra.0000361276.88339.44 · Cited by 17
Kulikov, A. V., Фурсенко, Д. В., Хоцкин, Н. В., Базовкина, Д. В., Kulikov, V. A., Naumenko, V. S., Bazhenova, E. Y., & Popova, N. K. (2014) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2014.04.009 · Cited by 17
Schröder, N., de Lima, M. N. M., Quevedo, J., Dal‐Pizzol, F., & Roesler, R. (2004) · Schizophrenia Research · doi:10.1016/j.schres.2004.06.015 · Cited by 17
Malkesman, O., Asaf, T., Shbiro, L., Goldstein, A., Maayan, R., Weizman, A., Kinor, N., Okun, E., Sredni, B., Yadid, G., et al. (2009) · Advances in Pharmacological Sciences · doi:10.1155/2009/405107 · Cited by 17
Serres, F., Millan, M. J., & Sharp, T. (2011) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145711000733 · Cited by 16
The role of GABAB receptors in depression and antidepressant‐related behavioural responses
Slattery, D. A., & Cryan, J. F. (2006) · Drug Development Research · doi:10.1002/ddr.20110 · Cited by 16
Chen, J., Newton, S. S., Zeng, L., Adams, D. H., Dow, A. L., Madsen, T. M., Nestler, E. J., & Duman, R. S. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300289 · Cited by 17
Gholami-Zanjanbar, M., Soleimanian, F., Reyhani, N., Hajizamani, S., Sajadi, A.-E., Ghofrani-Jahromi, Z., & Vaseghi, S. (2024) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2024.173894 · Cited by 15
Zhang, H., Wang, Q., Sun, Q., Qin, F., Nie, D., Li, Q., Gu, Y., Jiang, Y., Lu, S.-F., & Lu, Z. (2020) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-020-00848-9 · Cited by 15
Wakabayashi, Y., Stenkrona, P., Arakawa, R., Yan, X., Buskirk, M. G. V., Jenkins, M. D., Santamaria, J. A. M., Maresca, K. P., Takano, A., Liow, J., et al. (2022) · Journal of Nuclear Medicine · doi:10.2967/jnumed.122.263838 · Cited by 15
Hadaeghi, F., Golpayegani, M. R., & Murray, G. (2015) · Journal of Theoretical Biology · doi:10.1016/j.jtbi.2015.02.020 · Cited by 15
Genotype variant associated with add-on memantine in bipolar II disorder
Lee, S.-Y., Chen, S., Chang, Y.-H., Chen, S., Chu, C.-H., Huang, S., Tzeng, N., Wang, C., Wang, L., Lee, I. H., et al. (2013) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145713000825 · Cited by 15
Major affective disorders and schizophrenia: a common molecular signature?
Bogaert, A. V. D., Del‐Favero, J., & Broeckhoven, C. V. (2006) · Human Mutation · doi:10.1002/humu.20369 · Cited by 15
Lee, S. Y., Chen, S., Chang, Y., Chen, P.-S., Huang, S., Tzeng, N., Wang, C.-L., Wang, L.-J., Lee, I., Wang, T., et al. (2014) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.12324 · Cited by 14
Peripheral Biomarker Candidates of Posttraumatic Stress Disorder
Kang, H. J., Yoon, S. J., & Lyoo, I. K. (2015) · Experimental Neurobiology · doi:10.5607/en.2015.24.3.186 · Cited by 15
Muñoz-Cobo, I., Erburu, M. M., Zwergel, C., Cirilli, R., Mai, A., Valente, S., Puerta, E., & Tordera, R. M. (2018) · Psychopharmacology · doi:10.1007/s00213-018-4975-8 · Cited by 15
Ellenbroek, B. A., Angelucci, F., Husum, H., & Mathé, A. A. (2016) · Neuropeptides · doi:10.1016/j.npep.2016.05.001 · Cited by 15
Clinical, Research and Treatment Approaches to Affective Disorders
Juruena, M. F. (2012) · InTech eBooks · doi:10.5772/1482 · Cited by 14
From restoration of neuroplasticity to the treatment of depression: clinical experience
Silva, J. A. C. E. (2004) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2004.09.004 · Cited by 14
Ameliorative effect of BDNF on prenatal ethanol and stress exposure-induced behavioral disorders
Popova, N. K., Morozova, M. V., & Naumenko, V. S. (2011) · Neuroscience Letters · doi:10.1016/j.neulet.2011.09.066 · Cited by 14
A systematic review of the association between zinc and anxiety
Azargoonjahromi, A. (2023) · Nutrition Reviews · doi:10.1093/nutrit/nuad076 · Cited by 18
Role of the cAMP–PKA–CREB–BDNF pathway in abnormal behaviours of serotonin transporter knockout mice
Wang, X., Wang, K., Wu, X., Huang, W., & Yang, L. (2021) · Behavioural Brain Research · doi:10.1016/j.bbr.2021.113681 · Cited by 13
Chen, N., Zhao, M., Guo, Y., Wu, N., Cao, B., Zhan, B., Zhou, T., Li, Y., Zhu, F., Chen, W., et al. (2023) · Translational Psychiatry · doi:10.1038/s41398-023-02636-7 · Cited by 15
Park, S., Kim, B.-N., Kim, J.-W., Shin, M., Cho, S.-C., Kim, J.-H., Son, J.-W., Shin, Y., Chung, U., & Han, D. H. (2013) · Journal of Psychopharmacology · doi:10.1177/0269881113480989 · Cited by 13
Neurodevelopmental disorders and neurotoxicity: MicroRNA in focus
Jauhari, A., Singh, T., & Yadav, S. (2022) · Journal of Chemical Neuroanatomy · doi:10.1016/j.jchemneu.2022.102072 · Cited by 14
The status of the sensitization/kindling hypothesis of bipolar disorder
Post, R. M. (2004) · Current Psychosis & Therapeutics Reports · doi:10.1007/bf02629414 · Cited by 13
The anatomy of co-morbid neuropsychiatric disorders based on cortico-limbic synaptic interactions
Totterdell, S. (2006) · Neurotoxicity Research · doi:10.1007/bf03033236 · Cited by 13
Endocannabinoid Regulation of Monoamines in Psychiatric and Neurological Disorders
Bockstaele, E. J. V. (2013) · Springer eBooks · doi:10.1007/978-1-4614-7940-6 · Cited by 14
Olanzapine in bipolar disorder
Vieta, E. (2004) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.5.7.1613 · Cited by 13
Tadokoro, K., Hashimoto, R., Tatsumi, M., Kamijima, K., & Kunugi, H. (2004) · Neuropsychobiology · doi:10.1159/000079971 · Cited by 13
Is there a risk of esketamine misuse in clinical practice?
Roncero, C., Torres, M. M., Szerman, N., Torrens, M., Vega, P., Andrés-Olivera, P., & Alvarez, E. (2025) · Therapeutic Advances in Drug Safety · doi:10.1177/20420986241310685 · Cited by 16
Fujiwara, Y., Ihara, K., Hachisu, M., Suzuki, H., Kawai, H., Sakurai, R., Hirano, H., Chaves, P. H. M., Hashizume, M., & Obuchi, S. P. (2021) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2021.641608 · Cited by 13
Neurobiology of Severe Mood and Anxiety Disorders
Mann, J. J., Currier, D., Quiroz, J. A., & Manji, H. K. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-374947-5.00060-2 · Cited by 12
Plasma metabolites were associated with spatial working memory in major depressive disorder
Du, Y., Wei, J., Yang, X., Dou, Y., Zhao, L., Qi, X., Yu, X., Guo, W., Wang, Q., Deng, W., et al. (2021) · Medicine · doi:10.1097/md.0000000000024581 · Cited by 12
Johnston, C. A., Beazely, M. A., Bilodeau, M. L., ANDRISANI, O. M., & Watts, V. J. (2004) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2004.02285.x · Cited by 12
Xiao, Y., Luo, H., Yang, W. Z., Zeng, Y., Shen, Y., Ni, X., Shi, Z., Zhong, J., Liang, Z., Fu, X., et al. (2020) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2020.00048 · Cited by 12
Bayman, M. G., İnal, Z. Ö., Hayiroglu, F., Öztürk, E. N. Y., & Gezginç, K. (2022) · Journal of Obstetrics and Gynaecology · doi:10.1080/01443615.2021.2006159 · Cited by 11
Animal Models of Posttraumatic Stress Disorder
Cohen, H., Matar, M. A., & Zohar, J. (2008) · Humana Press eBooks · doi:10.1007/978-1-59745-285-4_61 · Cited by 11
Neue Erkenntnisse zur Pathogenese und Pathophysiologie der Depression
Schüle, C., Baghai, T. C., & Rupprecht, R. (2007) · Der Nervenarzt · doi:10.1007/s00115-007-2370-5 · Cited by 12
Nazari, S., Niknamfar, S., Ghazvini, H., Rafaiee, R., Allahverdy, A., Khazaie, H., & Tamijani, S. M. S. (2025) · Addiction Biology · doi:10.1111/adb.70016 · Cited by 10
Murthy, M. K. (2025) · Neuroscience · doi:10.1016/j.neuroscience.2025.08.009 · Cited by 13
Bipolar Disorder: A Neurobiological Synthesis
Manji, H. K., Henter, I. D., & Zarate, C. A. (2010) · Current topics in behavioral neurosciences · doi:10.1007/7854_2010_98 · Cited by 10
Mechanisms underlying the relationship between physical activity and anxiety:Animal data
Crocker, P. R. E., McEwen, C. E., & Mosewich, A. D. (2013) · Routledge eBooks · doi:10.4324/9780203132678-17 · Cited by 10
Differing psychotropic profiles of the anticonvulsants in bipolar and other psychiatric disorders
Post, R. M. (2004) · Clinical Neuroscience Research · doi:10.1016/j.cnr.2004.06.003 · Cited by 10
Effect of pharmacologically selective antidepressants on serotonin uptake in rat platelets.
Fišar, Z., Anders, M., & Kališová, L. (2005) · PubMed · Cited by 10
Synaptic priming: A framework for pharmacotherapy in depression
Brown, K. A., Ajibola, M. I., Medeiros, G. C., & Gould, T. D. (2025) · Neuron · doi:10.1016/j.neuron.2025.09.010 · Cited by 11
González‐Giraldo, Y., Camargo, A., López‐León, S., & Forero, D. A. (2015) · Depression Research and Treatment · doi:10.1155/2015/145483 · Cited by 9
Time-dependent activation of MAPK/Erk1/2 and Akt/GSK3 cascades: modulation by agomelatine
Musazzi, L., Seguini, M., Mallei, A., Treccani, G., Pelizzari, M., Tornese, P., Racagni, G., & Tardito, D. (2014) · BMC Neuroscience · doi:10.1186/s12868-014-0119-1 · Cited by 10
Hachisu, M., Hashizume, M., Kawai, H., Hirano, H., Kojima, M., Fujiwara, Y., Obuchi, S. P., & Ihara, K. (2017) · Geriatrics and gerontology international/Geriatrics & gerontology international · doi:10.1111/ggi.13210 · Cited by 9
Pharmacologic and non-pharmacologic interventions for emotional lability: A meta-analysis
Agapoff, J. R., Zhang, C., Meek, M., & van Schalkwyk, G. I. (2023) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2023.105184 · Cited by 9
Dwyer, D. S., & Dickson, A. (2006) · International review of neurobiology · doi:10.1016/s0074-7742(06)77008-8 · Cited by 9
MAKINO, A., Iinuma, M., Fukumitsu, H., Soumiya, H., Furukawa, Y., & Furukawa, S. (2013) · Biomedical Research · doi:10.2220/biomedres.34.259 · Cited by 9
In vitroeffect of antipsychotics on brain energy metabolism parameters in the brain of rats
Scaini, G., Rochi, N., Morais, M. O. D. S., Maggi, D. D., De-Nês, B. T., Quevedo, J., & STRECK, E. L. (2012) · Acta Neuropsychiatrica · doi:10.1111/j.1601-5215.2012.00650.x · Cited by 9
Manev, R. M., & Manev, H. (2004) · Medical Hypotheses · doi:10.1016/j.mehy.2004.05.013 · Cited by 9
Damm, J., Eser, D., Schüle, C., Möller, H. ‐., Rupprecht, R., & Baghai, T. C. (2009) · Der Nervenarzt · doi:10.1007/s00115-008-2660-6 · Cited by 9
Mandal, B., Kiran, M. R., & Singh, S. P. (2024) · Materials Advances · doi:10.1039/d4ma00209a · Cited by 8
Novel pharmacological treatments for generalized anxiety disorder: Pediatric considerations
Sonmez, A. I., Almorsy, A. G., Ramsey, L. B., Strawn, J. R., & Croarkin, P. E. (2020) · Depression and Anxiety · doi:10.1002/da.23038 · Cited by 9
Mitochondrial Functions in Mood Disorders
Hroudová, J., Fišar, Z., & Raboch, J. (2013) · InTech eBooks · doi:10.5772/53254 · Cited by 8
Glutamate and Neurodegeneration
Novelli, A., Pérez‐Basterrechea, M., & Fernández‐Sánchez, M. T. (2005) · Humana Press eBooks · doi:10.1007/978-1-59259-852-6_19 · Cited by 8
Schizophrenia: Modeling a complex psychiatric disorder
Arguello, P. A., & Gogos, J. A. (2006) · Drug Discovery Today Disease Models · doi:10.1016/j.ddmod.2006.12.004 · Cited by 7
Effects of different antidepressant treatments on the core of depression
Baghai, T. C., Eser, D., & Möller, H. (2008) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2008.10.3/tcbaghai · Cited by 7
Mandal, B., Kiran, M. R., & Singh, S. P. (2024) · Synthetic Metals · doi:10.1016/j.synthmet.2024.117778 · Cited by 6
Suárez-Cuenca, J., Campos-Nolasco, N. P., Rodríguez-Ayala, E., Zepeda-Làmbarry, A. D., Ochoa-Madrigal, M. G., Maldonado-Tapia, D., Vera-Gómez, E., Hernández-Patricio, A., Martínez-Torres, G., Bernal-Figueroa, Y., et al. (2025) · Renal Failure · doi:10.1080/0886022x.2025.2463561 · Cited by 5
Chou, Y.-H., Chen, C., Wang, S.-J., Tsai, S., Lirng, J.-F., Liou, Y., Lin, C.-L., Yang, K., Lin, M., Lo, W.-C., et al. (2013) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e3182904a80 · Cited by 6
Reda, M., El-Nady, H. G., Rabie, M. A., Abdelkawy, R. F. M., Adel, S., Awadallah, E. A., & Moneim, M. A. (2016) · Middle East Current Psychiatry · doi:10.1097/01.xme.0000481814.92893.e2 · Cited by 6
Pathophysiology of Mood Disorders and Mechanisms of Action of Antidepressants and Mood Stabilizers
Fišar, Z. (2013) · Springer eBooks · doi:10.1007/978-1-4614-7940-6_6 · Cited by 7
Hachisu, M., Hashizume, M., Kawai, H., Hirano, H., Kojima, M., Fujiwara, Y., Obuchi, S. P., Kogo, M., Ohbayashi, M., Koyama, N., et al. (2020) · Aging Pathobiology and Therapeutics · doi:10.31491/apt.2020.09.031 · Cited by 5
Apoptosis - the potential pathophysiological mechanism in mood disorders modifiable by lithium salts
Karlović, D. (2008) · Biochemia Medica · doi:10.11613/bm.2008.026 · Cited by 5
Fam, J. P., Westbrook, R. F., & Holmes, N. M. (2017) · Journal of Experimental Psychology Animal Learning and Cognition · doi:10.1037/xan0000140 · Cited by 5
Zarrinkalam, E., Arabi, S. M., Komaki, A., & Ranjbar, K. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e17992 · Cited by 4
Kwon, H., Jeon, J., Cho, E., Moon, S., Park, A. Y., Kwon, H. J., Kwon, K. J., Ryu, J. H., Shin, C. Y., Yi, J. H., et al. (2025) · Neuropharmacology · doi:10.1016/j.neuropharm.2025.110431 · Cited by 4
Neurotransmission in Mood Disorders
Fiar, Z., Hroudov, J., & Raboch, J. (2012) · InTech eBooks · doi:10.5772/31831 · Cited by 4
Ueno, T., Miki, T., Wang, Z., YOKOYAMA, T., Lee, K., Kusaka, T., Warita, K., Sumitani, K., Matsumoto, Y., Yakura, T., et al. (2010) · e-publications@bond (Bond University) · Cited by 4
Milosevic, L., Dallapiazza, R. F., Munhoz, R. P., Kalia, S. K., Popović, M. R., & Hutchison, W. D. (2019) · Journal of Neurophysiology · doi:10.1152/jn.00203.2019 · Cited by 4
Ma, X., Li, Q., Chen, G.-H., Xie, J., Wu, M., Meng, F., Liu, J., Liu, Y., Zhao, D., Wang, W., et al. (2023) · Neurochemical Research · doi:10.1007/s11064-023-03926-8 · Cited by 5
Chang, H. S., Lee, H., Ham, B., Park, Y. C., Hahn, S., Jeong, Y., Kim, B., & Lee, M.-S. (2012) · Asia-Pacific Psychiatry · doi:10.1111/j.1758-5872.2012.00219.x · Cited by 4
Ren, Y., Chen, W., Wang, J., Wu, S., Linghu, T., Ge, J., & Zhang, R. (2025) · Psychopharmacology · doi:10.1007/s00213-025-06898-5 · Cited by 3
Metadata
- Authors
- Duman, R. S.
- Affiliations
- Yale University (US)
- Corresponding author
- Duman, R S
- ORCID
- Duman, R S
- Venue
- Molecular Psychiatry
- Published
- 2002-01
- Volume
- 7
- Issue
- S1
- Pages
- S29-S34
- ISSN
- 1359-4184 (ISSN-L)
- 1476-5578
- OpenAlex
- W1983914274
- Cited by
- 363
- References
- 46
- Citations by year
- 2026: 2 · 2025: 10 · 2024: 6 · 2023: 8 · 2022: 8 · 2021: 4 · 2020: 11 · 2019: 6 · 2018: 12 · 2017: 7 · 2016: 10 · 2015: 8 · 2014: 12 · 2013: 18 · 2012: 21
- FWCI
- 3.26
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Molecular Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of Mental Health (2P01 MH25642, MH-45481, P01MH025642)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Keywords
- synaptic plasticity, mood disorders, depression, bipolar disorder, CREB, brain-derived neurotrophic factor, neurotrophic factors, transcription factors, atypical antipsychotics, clozapine, olanzapine, neural circuits, antidepressant mechanism
- MeSH terms
- Antidepressive Agents, Depressive Disorder, Humans, Synaptic Transmission, Neuronal Plasticity, Cyclic AMP Response Element-Binding Protein, Brain-Derived Neurotrophic Factor, Mood Disorders
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review